News and Analysis

Synthekine fetches $107.5m Series B

Synthekine Inc., an engineered cytokine therapeutics company, has secured $107.5 million in Series B financing.

-

Synthekine Inc., an engineered cytokine therapeutics company, has secured $107.5 million in Series B financing. Deerfield Management and Janus Henderson Investors led the round.

Source: Press Release